Shilpa Pharma, Inc. v. Novartis Pharmaceuticals Corporation

Case: 24-1181 Document: 39 Page: 1 Filed: 07/10/2025

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit

______________________ SHILPA PHARMA, INC., Appellant v.

NOVARTIS PHARMACEUTICALS CORPORATION,

Appellee ______________________

2024-1181 ______________________

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2022- 00886.

______________________ JUDGMENT ______________________

MARK BOLAND, Sughrue Mion, PLLC, Washington, DC, argued for appellant. Also represented by MICHAEL R. DZWONCZYK, RAJA SALIBA.

WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for appellee. Also represented by ELIZABETH A. KIERNAN, Gibson, Dunn & Crutcher LLP, Dallas, TX; JANE M. LOVE, ROBERT TRENCHARD, New York, NY.

______________________

Case: 24-1181 Document: 39 Page: 2 Filed: 07/10/2025 THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (MOORE, Chief Judge, STOLL, Circuit Judge, and BUMB, Chief District Judge1).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT July 10, 2025

Date